Wenzhuo J. Zhuang

Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

EZH2-dependent STAT3 stabilization drives pomalidomide resistance and is targetable by EZH2 inhibition in multiple myeloma.

EZH2-dependent STAT3 stabilization drives pomalidomide resistance and is targetable by EZH2 inhibition in multiple myeloma.

Journal: Acta biochimica et biophysica Sinica

Published: August 26, 2026

Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death.

Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death.

Journal: Apoptosis : an international journal on programmed cell death

Published: March 13, 2026

Comprehensive Driver Mutation Landscape of DLBCL Informed by Integrated Tissue and Circulating DNA Analyses.

Comprehensive Driver Mutation Landscape of DLBCL Informed by Integrated Tissue and Circulating DNA Analyses.

Journal: Cancer research and treatment

Published: January 26, 2026

Serum interleukin predicts the efficacy of immunotherapy for nasopharyngeal carcinoma: a prospective observational study

Serum interleukin predicts the efficacy of immunotherapy for nasopharyngeal carcinoma: a prospective observational study

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: December 24, 2025

Milk exosomes delivery of KPT-330 alleviates gastrointestinal adverse reactions and provides effective anti-diffuse large B-cell lymphoma therapy.

Milk exosomes delivery of KPT-330 alleviates gastrointestinal adverse reactions and provides effective anti-diffuse large B-cell lymphoma therapy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: November 21, 2025

MM-derived exosomes promote M2 macrophage polarization and immunosuppressive microenvironment: therapeutic opportunities.

MM-derived exosomes promote M2 macrophage polarization and immunosuppressive microenvironment: therapeutic opportunities.

Journal: Blood cancer journal

Published: November 04, 2025

High Magnetoresistance Sensitivity and Anisotropic Magnetotransport Properties in the Chiral Helimagnet Cr1/3NbS2.

High Magnetoresistance Sensitivity and Anisotropic Magnetotransport Properties in the Chiral Helimagnet Cr1/3NbS2.

Journal: The journal of physical chemistry letters

Published: February 10, 2025

Combined Inhibition of XPO1 and DNA Methylation Exerts Synergistic Effects in DLBCL.

Combined Inhibition of XPO1 and DNA Methylation Exerts Synergistic Effects in DLBCL.

Journal: Molecular carcinogenesis

Published: January 02, 2025

An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

Journal: Journal of nanobiotechnology

Published: December 20, 2024

Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.

Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.

Journal: Oncogenesis

Published: July 05, 2024

BCL6 confers resistance to HDAC inhibitors in DLBCL.

BCL6 confers resistance to HDAC inhibitors in DLBCL.

Journal: Biochemical pharmacology

Published: January 22, 2024

Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma.

Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma.

Journal: Blood advances

Published: December 19, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026